FilingReader Intelligence
Henlius Biotech reports revenue and profit growth
August 25, 2025 at 10:50 AM UTC•By FilingReader AI
Shanghai Henlius Biotech reported a 2.7% increase in revenue to RMB2,819.5 million for the six months ended June 30, 2025. Total profit rose RMB3.8 million to RMB390.1 million.
Revenue from overseas product sales reached RMB40.6 million, with profits more than doubling year-over-year due to strong U.S. market performance.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:2696•Hong Kong Exchange
News Alerts
Get instant email alerts when Shanghai Henlius Biotech, Inc publishes news
Free account required • Unsubscribe anytime